AstraZeneca, Daiichi hit first goal in pivotal breast cancer ADC trial
AstraZeneca and Daiichi Sankyo are coming for Gilead Sciences' breast cancer business. The partners plan to file for approval of...
Alzheimer's Expert Explains How Genetic Mutations Can Slow The Disease
Diseases that run in families usually have genetic causes. Some are genetic mutations that directly cause the disease if inherited....
AI shows major promise in breast cancer detection, new studies suggest
Researchers experimenting with artificial intelligence have found that these tools seem to reliably detect breast cancer, while also...
New blood test gives high accuracy screen for Alzheimer's disease
A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high...
